共 2 条
[1]
Thalidomide up-regulates prostate-specific antigen secretion from LNCaP cells.[J].Shannon C. Dixon;Erwin A. Kruger;Ken S. Bauer;William D. Figg.Cancer Chemotherapy and Pharmacology.1999, 1
[2]
Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101; a tumor-inhibiting anti-neovascularization agent; evaluated in phase I clinical trial.[J].Barbara D. Wamil;Gary B. Thurman;Hakan W. Sundell;Russel F. DeVore;Gail Wakefield;David H. Johnson;Yue-Fen Wang;Carl G. Hellerqvist.Journal of Cancer Research and Clinical Oncology.1997, 3